biotech
Biotech company Amgen set to build $600-million research center in Thousand Oaks
Biotech company Amgen is investing $600 million into a new research center for its Thousand Oaks campus. The new site will create hundreds of jobs and feature advanced automation...
China’s biotech moment ignites a 60% stock rally that beats AI
China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds are tipping further gains.The Hang Seng Biotech Index...
Merck held talks to buy biotech MoonLake for over US$3 billion: FT
Published Tue, Jun 3, 2025 · 07:45 AMMERCK has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, the Financial Times reported on Monday, citing...
Sanofi to buy immunology biotech Blueprint for US$9.1 billion
[PARIS] Sanofi agreed to buy Blueprint Medicines for at least US$9.1 billion as the French drugmaker expands further in rare immunological diseases.Sanofi will pay US$129 per share in cash...
Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion
[SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks to raise HK$1.09 billion (S$181 million) to further...
Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion
[SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks to raise HK$1.09 billion (S$181 million) to further...
Singapore-based biotech firm Nuevocor raises US$45 million in Series B round
[SINGAPORE] Biotechnology company Nuevocor announced on Wednesday (May 7) that it completed a US$45 million Series B funding round from new and existing investors. This includes “significant participation” from...
All assets of biotech founder in Novo Nordisk suit frozen, including US$218 million in DBS account
The Danish drugmaker alleges misrepresentations by KBP Biosciences founder Huang Zhenhua about the success of its kidney drug PHARMA giant Novo Nordisk has been granted an injunction by the...
Initial MAS review group incentives could pull in regional biotech, fintech players: observers
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, tooMARKET watchers believe tax incentives proposed by the Monetary Authority of Singapore’s (MAS) equities market review group...